Monitoring Enterovirus D68 In Children With Asthma

Enterovirus D68 (EV-D68) is a respiratory virus that can resemble a routine cold while occasionally causing severe wheezing, breathing difficulty, or neurological complications. Children with asthma may be especially important in early monitoring because a cluster of asthma-related respiratory presentations can become visible before test results identify the pathogen.

Syndromic surveillance provides a way to detect these patterns quickly. Instead of waiting for laboratory confirmation, public-health teams can examine changes in symptoms, diagnoses, ambulance calls, emergency visits, school absences, pharmacy purchases, and hospital admissions. The combined signal can indicate that an unusual respiratory event is developing in a particular age group or community.

For Australia, this approach needs to account for seasonal respiratory illness, long travel distances, school calendars, and differences between metropolitan and regional healthcare access. A rise in wheeze-related presentations in Melbourne may have a different explanation from a similar rise in a remote Queensland community, where local weather, staffing, transport, and testing availability shape the data.

Monitoring should therefore be sensitive without being alarmist. The aim is to identify meaningful clusters early, guide proportionate investigation, support families and clinicians, and strengthen outbreak response while protecting privacy.

Why EV-D68 Warrants Early Attention

EV-D68 spreads mainly through respiratory secretions and can circulate alongside influenza, respiratory syncytial virus, rhinoviruses, and other enteroviruses. Many infections are mild, so routine laboratory notifications may capture only a fraction of community transmission. A sudden increase in children presenting with wheeze, shortness of breath, chest tightness, or asthma exacerbation may offer an earlier indication that respiratory activity has changed.

The asthma connection is useful but not specific. Children with asthma can experience flare-ups after exposure to many viruses, smoke, pollen, cold air, or indoor irritants. EV-D68 surveillance must therefore look for an unusual combination of features: a sharp rise above the expected baseline, clustering by age or location, increased use of respiratory support, and a pattern that cannot be readily explained by influenza or another known cause.

In Australia, respiratory activity often varies between winter and the shoulder seasons, while schools, childcare centres, and household commuting can accelerate transmission. A cluster in Sydney, Brisbane, or Perth may appear first through emergency departments and pharmacies, whereas a regional cluster may be more visible through general practices, ambulance services, or school absenteeism.

Defining Respiratory Illness Clusters

A useful cluster definition should combine time, place, age, and clinical presentation. Examples include several children from the same school zone attending emergency care for acute wheeze within a few days, or a sustained increase in asthma exacerbations among children aged five to fourteen across multiple suburbs. The definition should be established before a signal appears so that changing criteria do not create a misleading result.

Data fields can include symptom onset, age band, postcode or statistical area, asthma history, oxygen saturation, admission status, ventilation, and whether a respiratory specimen was collected. Coded information is usually more practical than free-text notes for rapid analysis. Terms such as “viral-induced wheeze”, “acute bronchospasm”, “shortness of breath”, and “asthma flare” can be mapped into a common syndrome category.

The baseline should reflect local behaviour and service use. School holidays can reduce school-based signals while increasing family travel and urgent-care attendance. Public holidays may delay general-practice visits, and a cold snap may increase presentations without any change in viral transmission. Analysts should compare current counts with several previous years and with nearby areas that have similar population and healthcare characteristics.

Combining Australia’s Surveillance Channels

A multi-channel model can connect emergency departments, hospital admissions, ambulance dispatches, general practices, pharmacies, schools, aged-care services, and laboratories. Each source has a different delay and bias. Ambulance data may show severity early, pharmacy data may reflect community demand, and school absence can reveal spread among children before hospitals experience pressure.

Pharmacy surveillance is particularly valuable when it tracks purchases associated with respiratory illness, such as reliever inhalers, spacers, children’s analgesics, or selected cough and cold products. These indicators must be interpreted carefully because over-the-counter purchasing habits vary, medicines may be bought in advance, and Australian pharmacy sales are influenced by prescription rules, supply conditions, and seasonal advertising.

School absenteeism can supply a geographically detailed signal, especially when schools record unexplained illness separately from planned leave. A cluster of absences with respiratory symptoms is more informative than total absence alone. Linking school data to health-service indicators should use aggregated areas and minimum-count rules so that individual children cannot be identified.

A multi-channel surveillance model can help public-health teams coordinate these streams rather than treating each one as an isolated alert. During major sporting events, festivals, or international conferences, enhanced monitoring may be needed because visitors, crowded accommodation, and altered healthcare-seeking behaviour can change the normal pattern.

Interpreting Asthma-Linked Patterns

The key analytical question is whether asthma-related respiratory activity is higher, earlier, or more severe than expected. A simple count of presentations is rarely sufficient. Teams should examine rates per child population, the proportion of presentations involving wheeze, repeat attendance, admission rates, ambulance transport, and the distribution of cases across schools or local government areas.

Laboratory testing can then be targeted to the most informative specimens rather than applied indiscriminately. A rise in syndrome activity may justify testing a sample of patients from different locations and time points. Results can help distinguish EV-D68 from influenza, COVID-19, respiratory syncytial virus, human rhinovirus, and other causes of paediatric respiratory illness.

Asthma status should be treated as a risk marker, not proof of EV-D68 infection. Some children may have undiagnosed asthma, while others may be incorrectly coded as having asthma during an acute wheezing episode. Analysts should retain separate categories for established asthma, suspected reactive airway disease, and no recorded respiratory history where possible.

Interpretation also needs clinical context. Bushfire smoke, hazard-reduction burns, dust storms, pollen seasons, and poor indoor ventilation can increase wheeze across Australia. A signal that coincides with smoke exposure may require an air-quality response as well as an infectious-disease investigation.

Moving From Signal To Response

An alert should trigger a defined verification process rather than an automatic public warning. Epidemiologists can review the size and growth of the cluster, check data quality, compare multiple sources, contact affected services, and request laboratory testing. Clinicians can be reminded to collect suitable specimens and report severe or unusual presentations through established state or territory pathways.

Hospitals and primary-care services may need practical guidance on triage, infection prevention, respiratory assessment, and escalation for children with breathing difficulty. Families need clear advice about warning signs and when to seek urgent care, especially in communities where the nearest emergency department is far away. Messages should avoid suggesting that every asthma flare is caused by EV-D68.

Communication should be coordinated with state and territory health authorities, schools, respiratory clinicians, laboratories, and Aboriginal Community Controlled Health Services. Local knowledge is essential in remote and culturally diverse communities, where transport, language, housing conditions, and access to regular asthma care can affect both illness and reporting.

The public-health response should be proportionate to the evidence. A small, localised cluster may require enhanced testing and clinical awareness. A broad increase in severe illness may justify wider communication, additional hospital preparedness, and closer monitoring of school and pharmacy indicators.

Privacy, Governance, And Data Quality

Surveillance involving children requires strong governance. Data systems should collect only what is needed, limit access by role, and report results in aggregated form. Australian agencies must consider the Privacy Act 1988 where applicable, as well as state and territory health-record legislation, public-health powers, contractual requirements, and local ethics processes.

Postcodes, school names, and rare clinical details can create re-identification risks when a cluster is small. Suppression thresholds, secure linkage, retention limits, audit trails, and clear data-sharing agreements should be built into the system from the start. A public dashboard should never expose enough detail to identify an individual child, family, or classroom.

Data quality checks are equally important. A sudden increase may reflect a hospital coding change, a new electronic medical record, a pharmacy supply disruption, a school reporting policy, or a laboratory campaign. Teams should document such changes and use validation samples, denominator checks, duplicate removal, and comparisons with independent sources.

Australia’s health system is distributed across Commonwealth, state, territory, local, private, and community providers. Clear ownership is needed for alert review, laboratory referral, communication, and follow-up. Without agreed responsibilities, a technically impressive signal may not lead to timely action.

Signals Worth Reviewing

The following indicators can be reviewed daily or weekly, depending on the level of respiratory activity:

• Paediatric emergency visits coded for wheeze, bronchospasm, or asthma exacerbation
• Ambulance call-outs involving breathing difficulty in school-aged children
• School absences linked to respiratory symptoms across nearby locations
• Pharmacy demand for reliever inhalers, spacers, or related respiratory products

A second group of measures helps distinguish a growing cluster from ordinary seasonal variation:

• The proportion of tested specimens positive for EV-D68 or another respiratory pathogen
• Hospital admissions, intensive-care use, or oxygen support among affected children
• Geographic spread across schools, suburbs, local government areas, or health districts
• The interval between symptom onset, healthcare attendance, specimen collection, and reporting

These indicators should be viewed together. A rise in pharmacy purchases without increased clinical presentations may reflect stockpiling, while a rise in emergency visits with stable admissions may indicate greater attendance but not greater severity. A consistent signal across independent channels is more credible than a dramatic change in one source.

Learning From Comparable Surveillance Work

Public-health teams can use documented examples to understand how early-warning systems combine data, establish thresholds, and verify alerts. The surveillance case studies offer a useful reference point for designing a workflow that connects routine monitoring with rapid investigation.

An Australian implementation could begin with a small pilot in one metropolitan health district and one regional or remote setting. The pilot could compare emergency presentations, school absenteeism, pharmacy indicators, and laboratory results over a full respiratory season. This would reveal which channels are timely, which are most affected by local practice, and where reporting gaps need attention.

Evaluation should measure sensitivity, timeliness, false-alert frequency, representativeness, and usefulness to clinicians. It should also assess whether alerts reach decision-makers early enough to change testing, hospital preparation, or public communication. A system that produces many notifications but little actionable information may need simpler thresholds or better integration.

The goal is a sustainable monitoring cycle: collect, clean, compare, verify, communicate, and review. That cycle can support EV-D68 detection while remaining useful for other respiratory threats, including influenza, COVID-19, and emerging pathogens.

Building a child-focused respiratory cluster system gives Australian health services an earlier view of unusual illness in communities where laboratory confirmation may lag. By combining asthma-related presentations with school, ambulance, pharmacy, hospital, and laboratory information, teams can recognise meaningful change without treating every fluctuation as an outbreak.

Health departments, hospitals, primary-care networks, schools, laboratories, and community health organisations can begin by agreeing on a shared syndrome definition, privacy safeguards, escalation pathway, and small set of indicators. Used consistently, syndromic surveillance can turn scattered observations into timely evidence for protecting children with asthma and strengthening respiratory outbreak preparedness.